pidemiological studies reveal that the risks of cardiovascular diseases such as hypertension, stroke, and coronary heart disease are inversely related to birth weight and independent of genetic factors and lifestyle 1 ; the mechanisms underlying this programming of diseases are currently incompletely understood. It has been suggested that a poor nutrient supply at a critical period of early development leads to permanent alteration of the developing vascular structures or functions. 2 This concept has been supported by animal studies demonstrating an association between nutritional deficit during intrauterine life and increased blood pressure in adulthood. 3 Studies in humans have reported endothelium dysfunction, 4 decreased vascular compliance, 5 and atherosclerosis 6 in children and adults with low birth weight. Similarly, chronic hypertension is associated with reduced endotheliumdependent vascular relaxation due in part to loss of nitric oxide (NO) generation before the onset of vascular dysfunc-tion. 7 NO is produced by endothelial nitric oxide synthase (eNOS) and plays a major role in the regulation of blood pressure and vascular tone. 8 NOS inhibitors increase blood pressure in animals and humans, 9 and mice with a disrupted eNOS gene are hypertensive. 10 The present studies were undertaken to test the hypothesis that hypertension and vascular dysfunction associated with in utero nutrient deprivation are secondary to "programmed" alterations in NO-dependent vasorelaxant pathways in microvasculature of a major organ, namely, brain. For this purpose, we used an animal model of fetal programming of hypertension in which mild restriction of protein intake of the pregnant rat leads to offspring with high blood pressure. 3 In these hypertensive rats, we studied the NO-dependent vasodilatation pathway of cerebral resistance microvessels because of their role as major regulators of cerebral circulation. 11 Our findings confirm impaired NO-mediated vasodilatation in hypertensive rats exposed to a low protein diet and reveal that this involves reduced soluble guanylate cyclase (sGC) expression and cGMP levels, whereas NO synthase (NOS) expression and function are normal. These findings provide an uncommon mechanism of microvascular dysfunction associated with chronic hypertension (secondary to in utero protein deprivation).
Materials and Methods

Animals
Animals were used according to a protocol of the Animal Care Committee of the Hôpital Sainte-Justine in accordance with the Guide for the Care and Use of Experimental Animals of the Canadian Council on Animal Care.
Virgin Wistar rats (weight, 225 to 250 g) were mated overnight and on the day of conception were allocated to be fed with isocaloric diets containing either 18% (control), 9% (low), or 6% (very low) protein (casein). 12 Within 12 hours of delivery, dams were returned to regular rat chow, and 4 to 5 pups per litter were weighed. Pups were weaned at 4 weeks of age to regular chow.
Systolic blood pressure of the offspring was determined from 7 to 12 weeks of age by the tail-cuff method (Harvard) by the same person. In a separate group of 10-to 12-week-old animals in the 9% group, the angiotensin-converting enzyme inhibitor enalaprilat (0.9 mg/kg per day) 13 (nϭ3) or saline (nϭ2) was infused (Alzet osmotic pumps, Durect Corporation). Blood pressure was determined daily. After 1 week of treatment, brain tissues were collected to study vasomotor response.
Isolation of Brain Tissues
Rats (9 to 12 weeks old) were decapitated, and brains were rapidly removed and placed in cold Krebs' buffer to which 1.5 U/mL heparin was added. For biochemical measurements, tissues were frozen in liquid N 2 and stored at Ϫ80°C.
Slices of brain (1 mm thick) exposing the pial microvessels were prepared as previously described 14 to study the relatively undisturbed cerebral vasculature (40 to 60 m).
Vasomotor Response
Brain microvessels were visualized and recorded with a video camera (model CCD72, MTI) mounted on a dissecting microscope (model M-400, Nikon), as previously reported. 14 Vascular diameter was measured with a digital image analyzer (Sigma Scan software, Jandel Scientific) and repeated 3 times with a variability of Ͻ1%.
Responses to vasorelaxant agents were determined on tissues precontracted with the thromboxane A 2 (TXA 2 ) mimetic U46619 (0.3 mol/L) to 50% of maximum contraction; the contraction to U46619 was not modified by the maternal diets. Vascular diameter was recorded before and after topical application of the following agents: acetylcholine, substance P, and prostacyclin (prostaglandin I 2 [PGI 2 ]); the NO donor sodium nitroprusside (SNP); a stable cGMP analogue 8-bromo cGMP 15 ; a selective protein kinase G stimulant, ␤-phenyl-1,N 2 -etheno-8-bromoguanosine-3Ј,5Ј-monophosphate (8-bromo PET cGMP) 16 ; and the K Ca channel agonist NS1619 in the absence or the presence (30 minutes of pretreatment) of GC inhibitor 1H-(1,2,4) oxidiazolo (4,3-a) quinoxaline-1-one (ODQ) (0.1 mmol/L) and the K Ca channel blocker iberiotoxin (100 nmol/L).
Preparation of Microvessels
Cortical microvessels were isolated as previously reported. 17 Briefly, cortical tissue was collected in ice-cold PBS (pH 7.4), cut into small pieces, and centrifuged at 1000 rpm for 10 minutes at 4°C. Pellets were suspended in PBS, mixed with Ficol 400 (20%) at a 1:1 (vol/vol) ratio, and centrifuged at 13 000 rpm for 20 minutes at 4°C, then washed 3 times in PBS.
Determination of NOS Activity
NOS activity of isolated cortical microvessels was measured by quantifying the conversion of L-arginine to L-citrulline with the use of a commercially available kit (Bioxytech NOS Assay Kit, Oxis International). Briefly, protein extracted from microvessels was incubated with radiolabeled L-arginine in the presence or in the absence of 1 mmol/L NOS inhibitor N G -nitro-L-arginine methyl ester. The reaction was terminated by the addition of 50 mmol/L HEPES buffer containing 5 mmol/L EDTA. Radiolabeled L-citrulline was counted after removal of excess L-arginine with an equilibrated resin and centrifugation.
NADPH-Diaphorase Histochemistry
NADPH-diaphorase reactivity was performed as previously described. 18 Briefly, tissue from cortex was fixed by immersion in 4% buffered paraformaldehyde containing 0.1% ␤-NADPH, 0.3% Triton X-100, 0.5 mmol/L MgCl 2 , 0.01 mol/L sodium azide, and 0.1% nitroblue tetrazolium. After they were processed, the slides were counterstained with neutral red. The intensity of staining in blood vessels was analyzed digitally with the software ImageProϩ4.1 (Media Cybernetics) and Photoshop 5 (Adobe).
Western Blotting
Western blotting analysis of microvessels lysates was performed as described. 18 Twenty-five micrograms of solubilized protein was probed with the following antibodies: anti-eNOS monoclonal antibody (1:1000); anti-sGC polyclonal antibody (1:1000); and anti-BK Ca channel polyclonal antibody (1:1000).
cGMP Radioimmunoassay cGMP was measured by radioimmunoassay on protein extracted from homogenates of cortical tissue with the use of a commercially available kit, as previously reported. 19 
Chemicals
The following agents were purchased: 8-bromo PET cGMP and 8-bromo cGMP (Biolog); SNP, acetylcholine, substance P, iberiotoxin, EDTA, HEPES, ␤-NADPH, Triton X-100, nitroblue tetrazolium, ODQ, and U46619 (Sigma Chemical); enalaprilat (Vasotec, Merck Frosst); NS1619 (Research Biochemicals International); Ficol and cGMP assay kits (Amersham); anti-eNOS monoclonal antibody (Transduction Laboratories); anti-sGC polyclonal antibody (Cayman Chemicals); anti-BK Ca channel polyclonal antibody (Alomone Labs); and horseradish peroxidase-conjugated goat anti-rabbit or antimouse IgG and Super Signal Western blot analysis system (Pierce). Other high-purity chemicals were purchased from Fischer Scientific.
Statistical Analysis
All results are expressed as meanϮSEM. 
Results
Effects of Low Protein Diet on Animal Weight and Litter Size
Net weight gain during pregnancy of dams in the 9% (144Ϯ7 g; nϭ18) and control (18%) (142Ϯ5 g; nϭ19) groups was similar but was reduced for dams in the 6% group (125Ϯ11 g; nϭ5). Dietary protein affected neither the litter size (18%: 14.8Ϯ0.7; nϭ8; 9%: 14.9Ϯ0.9; nϭ7; 6%: 14.3Ϯ0.8; nϭ7) nor the survival rate of offspring during the 14 weeks of the study period. Birth weight of the 9% group (5.3Ϯ0.1 g; nϭ14) tended to be slightly (but not significantly) less than that of the control (18%) group (5.6Ϯ0.2 g; nϭ14); pups born to dams in the 6% group were significantly lighter (4.5Ϯ0.1 g; nϭ14) than those in the other groups.
Effects of Antenatal Diet on Blood Pressure
The systolic blood pressure of offspring of mothers fed a low protein diet was higher than that of the control (18%) group throughout the study period ( Figure 1 ). We focused on offspring of the 9% and 18% groups because the very low protein diet did not cause further increases in blood pressure but was detrimental to fetal and maternal weight gain.
Effects of TXA 2 Mimetic, PGI 2 , and NO-Releasing Agents on Brain Microvessel Vasomotor Response
Constriction to the TXA 2 mimetic U46619 and dilatation to carba-PGI 2 did not differ between diet groups (Figure 2A and 2B). In contrast, maximum relaxation evoked by NOreleasing agents ( Figure 2C and 2D) was markedly decreased by approximately 50% in the 9% group; EC 50 values were increased for acetylcholine but only marginally so for substance P in rats in the 9% group (Table) .
eNOS in Brain Microvessels
eNOS protein expression, NOS activity, and NADPH diaphorase reactivity did not differ between the diet groups ( Figure 3 ).
Effects of Diet on Microvessel Response to SNP and cGMP Analogues and on cGMP Levels and Expression
Vasorelaxation to the NO donor SNP was decreased by 50% ( Figure 4A ) in the low protein group; EC 50 differed negligibly (Table) . Normalization of blood pressure in the 9% group with the use of an angiotensin-converting enzyme inhibitor for 1 week did not alter vasomotor response to SNP ( Figure  4B ). cGMP levels and immunoreactive sGC (␣ subunit) were approximately 3-to 4-fold lower in cortical brain microvessels of the 9% group ( Figure 4C and 4D) ; similar results were obtained for the ␤ protein subunit (data not shown). In addition, relaxation to cGMP analogue (8-bromo cGMP) and selective cGMP-dependent kinase stimulant (8-bromo PET cGMP) did not differ between diet groups ( Figure 4E and Table) .
Relative Contribution of GC and K Ca Channels in NO-Induced Relaxation
Because vasorelaxant effects of NO can be mediated to a significant extent by K Ca channels in addition to cGMP, 20, 21 we investigated the relative contribution of these factors. The role of K Ca may also be of interest because its activity may be augmented in a compensatory manner in hypertension. 22 Inhibition of both GC (with ODQ) and K Ca channel (with iberiotoxin) abolished SNP-evoked vasorelaxation regardless of diet ( Figure 5A ). Blockade of K Ca or of GC inhibited to a comparable extent (25% to 30%) the SNP-induced response in both groups. Correspondingly, there was no difference in immunoreactive K Ca protein expression ( Figure 5B ) or in the vasodilatation evoked by the K Ca opener NS1619 between the groups ( Figure 5C and Table) .
Discussion
There is convincing epidemiological evidence that maternal protein deficiency is associated with vascular dysfunction and Figure 1 . Effects of maternal diets containing 18% (control), 9% (low), and 6% (very low) protein on systolic blood pressure of offspring from 7 to 12 weeks of age (nϭ17, nϭ18, and nϭ6 animals for control, low, and very low protein groups, respectively). Data are meanϮSEM. *PϽ0.05.
Figure 2.
Vasoconstrictor response to U46619 (A) and vasorelaxant response to prostacyclin (PGI 2 ) (B), substance P (C), and acetylcholine (Ach) (D) on brain pial microvessels of 9-to 12-week-old rats exposed during gestation to a low protein (9%) or control (18%) diet. Effects of agents were studied in situ on brain slices, as described in Materials and Methods. Constriction is the percent reduction in vascular diameter from basal values, which were 42.5Ϯ3.2 and 44.1Ϯ2.6 m, respectively, for 9% and 18% groups. Relaxation is expressed as percent reversal of vasoconstriction induced by U46619 (0.3 mol/L). Data are meanϮSEM of 4 to 6 experiments. *PϽ0.05 compared with control (2-way ANOVA).
hypertension in adult life. 23 Since endothelial dysfunction with impaired NO production is an important pathophysiological element underlying hypertension and atherosclerosis, we tested the hypothesis that NO-dependent vasodilatation is altered in hypertension programmed during fetal life. Our results reveal that hypertension in adult rats induced by exposure to a low protein diet during intrauterine life is indeed associated with an altered NO-dependent vasorelaxation, which cannot be attributed to decreased NO production but rather to changes in the cGMP pathway.
We have reproduced a rat model in which pregnant dams are fed a diet containing 9% protein. 12 
Values are meanϮSEM of 3 experiments for each group. C, Brain slices were fixed for NADPH-diaphorase staining of blood cortical vessels; arrows point to the NADPH-diaphorase-reactive vessels. Tonality densitometry was analyzed as described in Materials and Methods. Lighter arbitrary tonality units correspond to reduced densitometry (histogram).
the control diet this is a 50% reduction in protein content, the 9% diet provided 75% of the basic protein requirements of a pregnant rat. 25 Birth weights of pups of dams fed a diet containing 9% protein are slightly but not significantly reduced, as reported by others. 26, 27 The hypertension observed in animals exposed to a low protein diet therefore implies fetal programming, which is defined as a permanent or long-term change in the physiology and morphology of organs in response to a specific stimulus at a critical period in development. 28 Along these lines, although offspring of dams fed a low protein diet exhibited only a modest reduction in mean outer vessel diameter (42.5 versus 44.1 m in controls), eutrophic remodeling of vessel structure associated with increased media-to-lumen ratio may contribute to these observations, as reported in other hypertensive conditions. 29 NO is a potent endogenous vasodilator. Endothelial dysfunction with decreased synthesis of endothelium-derived NO is present in hypertensive patients 7 and may initiate or contribute to diseases such as atherosclerosis, stroke, and hypertension. 8 In humans with lower birth weight, vascular dysfunction has been suggested by altered response to acetylcholine, 30 decreased arterial distensibility, 5 and increased risk of atherosclerosis. 6 Our findings reveal a decreased vasorelaxation to NO-dependent mechanisms in offspring of dams fed low protein diets due to reduced activity of the GC pathway. This impaired vasorelaxation to NO is not secondary to the hypertension per se since it persisted in rats in the 9% group with normalized blood pressure. eNOS expression and activity were unaltered by diets, whereas expression and activity of sGC, the main target of NO, were reduced in the 
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Stroke December 2002 low protein diet group. Since sGC is primarily located in the smooth muscle of vasculature, our observations disclose an uncommon feature in the pathogenesis of hypertension, in this case associated with a low protein diet during fetal development involving primarily a smooth muscle rather than endothelial functional defect. Of interest, decreased sGC expression and cGMP production as a mechanism for impaired vasodilatation have been described in the black population 31 (susceptible to hypertension), after subarachnoid hemorrhage, 32 and in pulmonary hypertension. 33 Similarly, decreased vasodilator potency of SNP on sGC activity 34 and downregulation of components of the sGC-dependent pathway 35 have been demonstrated in aged and spontaneously hypertensive rats. The underlying mechanisms and regulatory processes that govern sGC levels and function are not well known but may involve cAMP, phosphodiesterases, 32 nerve growth factor, and cytokines, 36 all of which may participate in atherosclerosis and vascular dysfunction. Although NO-evoked relaxation of pial arteries has been documented to be independent of K Ca in newborn pig, 37 others have reported K Ca to mediate a significant portion of NOevoked relaxation, 20, 21 including NO-induced vasodilation of rat cerebral arteries independent of cGMP. 38 Our findings support the latter inference, such that abolition of NO-elicited relaxation required inhibition of both K Ca and GC. On the other hand, one would have anticipated a relatively increased contribution of K Ca in the low protein group, 22 but this was not the case. Indeed, acute inhibition of either GC or K Ca pathways yielded only a small diminution of NO-evoked relaxation, suggesting compensation by the alternate pathway. However, since K Ca expression and vasorelaxant activity were unaltered by diet, it may be possible that its endogenous activity is diminished or that the activity of other related K Ca channels is unaltered or augmented, as reported in certain forms of hypertension. 39 In conclusion, our findings demonstrate impaired NOmediated vasodilatation of major resistance cerebral microvessels in a model of fetal programming of hypertension by protein deprivation and reveal that this involves an uncommonly described mechanism, specifically reduced sGC expression and cGMP levels with normal NOS expression and function. This impaired NO-dependent vasodilatation, which is unrelated to NO production and which seems to involve smooth muscle cell dysfunction, is an uncommonly described mechanism associated with chronic hypertension and may provide a pathophysiological explanation for relaxation dysfunction in subjects previously exposed in utero to nutrient deficiency.
